First patients sought for groundbreaking blood cancer drug trial
NCT ID NCT07226843
Summary
This is the first study in people testing a new drug called LY4584180 for adults with certain blood cancers that have come back or stopped responding to previous treatments. The main goals are to find a safe dose, see how the body processes the drug, and check for early signs that it might help shrink tumors. The study will enroll about 360 adults who have already tried at least two other treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AIDPORT Sp. z o.o.
Skorzewo, 60-185, Poland
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
CHU Bordeaux - Hopital Haut-Leveque - Centre Francois Magendie
Pessac, 33604, France
-
CHU de Nantes - Hotel-Dieu
Nantes, 44093, France
-
Cancer Institute Hospital of JFCR
Tokyo, 135-8550, Japan
-
Charite Universitaetsmedizin Berlin
Berlin, 10117, Germany
-
City of Hope
Duarte, California, 91010, United States
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218, United States
-
Columbia University
New York, New York, 10032, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Derriford Hospital
Plymouth, PL6 8DH, United Kingdom
-
Emory University Hospital
Atlanta, Georgia, 30322, United States
-
Florida Cancer Specialists - Sarasota
Sarasota, Florida, 34236, United States
-
Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
HCL Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant Orsola
Bologna, 40138, Italy
-
Institut Catala d'Oncologia - L'Hospitalet
Barcelona, 08908, Spain
-
Institut Curie
Paris, 75005, France
-
Instytut Hematologii i Transfuzjologii w Warszawie
Warsaw, 02-776, Poland
-
Istituto Europeo di Oncologia
Milan, 20141, Italy
-
King's College Hospital
London, SE5 9RS, United Kingdom
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic - Rochester
Rochester, Minnesota, 55905, United States
-
Mayo Clinic - Scottsdale
Scottsdale, Arizona, 85259, United States
-
National Cancer Center Hospital East
Chiba, 277-8577, Japan
-
Nottingham City Hospital
Nottingham, NG5 1PB, United Kingdom
-
Oncopole Claudius Regaud
Toulouse, 31059, France
-
Oregon Health & Science University (OHSU)
Portland, Oregon, 97239, United States
-
Pratia MCM Krakow
Krakow, 30-727, Poland
-
Pratia Onkologia Katowice
Katowice, 40-519, Poland
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz
Madrid, 28040, Spain
-
Texas Oncology - DFW (Sammons CC)
Dallas, Texas, 75246, United States
-
The Ohio State University (OSU)
Columbus, Ohio, 43210, United States
-
Universitaetsklinikum Essen
Essen, 45147, Germany
-
Universitaetsklinikum Frankfurt - Klinikum der Johann Wolfgang Goethe Universitaet
Frankfurt am Main, 60590, Germany
-
Universitaetsklinikum Koeln (AoeR)
Cologne, 50937, Germany
-
University Hospital Southampton NHS Foundation Trust
Southampton, SO16 6YD, United Kingdom
-
University of California, Los Angeles (UCLA) - Medical Center
Los Angeles, California, 90059, United States
-
University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center
San Francisco, California, 94158, United States
-
University of Miami - Sylvester Cancer Center
Miami, Florida, 33136, United States
-
University of Rochester
Rochester, New York, 14642, United States
-
University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance)
Seattle, Washington, 98195, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
Conditions
Explore the condition pages connected to this study.